TYK59: Difference between revisions
Jump to navigation
Jump to search
m (1 revision imported) |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
Which of the following is NOT a proposed mechanism of airway clearance with nebulized hypertonic saline? | Which of the following is NOT a proposed mechanism of airway clearance with nebulized hypertonic saline? | ||
| Line 10: | Line 9: | ||
D. Disruption of mucous strand cross-linking | D. Disruption of mucous strand cross-linking | ||
<div class="mw-customtoggle-TYK_Answer" style="text-align: right; color:#0000ff">Click for Answer</div> | |||
<div class="mw-collapsible mw-collapsed" id="mw-customcollapsible-TYK_Answer"> | |||
<div class="mw-collapsible- | |||
==Answer== | ==Answer== | ||
The answer is B. A recent article showed a 26% reduction in length of stay in infants with viral bronchiolitis treated with hypertonic saline. These are routinely used in children with cystic fibrosis. Although they showed no adverse events, many people mix albuterol/racemic epinephrine with hypertonic saline for fear that hypertonic saline may cause bronchospasm in sensitive individuals (atopic kids). | The answer is B. A recent article showed a 26% reduction in length of stay in infants with viral bronchiolitis treated with hypertonic saline. These are routinely used in children with cystic fibrosis. Although they showed no adverse events, many people mix albuterol/racemic epinephrine with hypertonic saline for fear that hypertonic saline may cause bronchospasm in sensitive individuals (atopic kids). | ||
==Notes== | ==Notes== | ||
<references /> | <references /> | ||
==Keywords== | ==Keywords== | ||
</div> | </div> | ||
---- | ---- | ||
---- | ---- | ||
Latest revision as of 22:59, 23 January 2022
Which of the following is NOT a proposed mechanism of airway clearance with nebulized hypertonic saline?
A. Reduction of mucosal edema
B. Brochodilation
C. Removal of inspissated mucus through osmotic hydration
D. Disruption of mucous strand cross-linking
Click for Answer
Answer
The answer is B. A recent article showed a 26% reduction in length of stay in infants with viral bronchiolitis treated with hypertonic saline. These are routinely used in children with cystic fibrosis. Although they showed no adverse events, many people mix albuterol/racemic epinephrine with hypertonic saline for fear that hypertonic saline may cause bronchospasm in sensitive individuals (atopic kids).
Notes